跳至主要内容
临床试验/ACTRN12610000072011
ACTRN12610000072011已完成不适用

Transurethral Enucleation and Resection of Prostate and Transvesical Prostatectomy for benign prostate hyperplasia (BPH) patients with prostate volume greater than 80ml, the primary outcomes include International Prostate Symptom Score (IPSS) and Quality of Life Score (QoLS)

xie, keji0 个研究点目标入组 100 人开始时间: 2010年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
50 Years 至 90 Years(—)
性别
Male

入选标准

  • benign prostate hyperplasia (BPH) with prostate>80ml: The prostate volume is measured by transrectal ultrasound conform to this equation: the volume equals 0.52 × (L × W × H), where L is the maximum length (craniocaudal dimension), H is the maximum height (anteroposterior dimension), both were obtained from the sagittal plane, W is the maximum width (transverse dimension) obtained from the transverse plane.

排除标准

  • neurologic problem and Bladder stone

研究者

发起方
xie, keji

相似试验